RT @ericdeinmd: #ACR21 L10 TRAIL1: Pirfenidone for RA-ILD âï¸Low pt enrollment due to pandemic, 1/2 of planned trial
Tweet Content
#ACR21 L10 TRAIL1: Pirfenidone for RA-ILD
⭐️Low pt enrollment due to pandemic, 1/2 of planned trial size
▶️ Unable to meet primary endpt (composite death+FVC) but met FVC markers. Most pronounced in UIP patterns on HRCT
@Rheumnow https://t.co/HB7N9Wl9Dn https://t.co/muBEguAAja
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off